My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 121

    1.

    Efficacy of atomoxetine in adult attention-deficit/hyperactivity disorder: a drug-placebo response curve analysis.

    Faraone SV, Biederman J, Spencer T, Michelson D, Adler L, Reimherr F, Glatt SJ.

    Behav Brain Funct. 2005 Oct 3;1:16.PMID: 16202140 [PubMed]Free PMC ArticleFree textRelated citations

    2.

    [Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents]

    Purper-Ouakil D, Fourneret P, Wohl M, Rénéric JP.

    Encephale. 2005 May-Jun;31(3):337-48. Review. French. PMID: 16142049 [PubMed - indexed for MEDLINE]Related citations

    3.

    Efficacy and safety of atomoxetine in childhood attention-deficit/hyperactivity disorder with comorbid oppositional defiant disorder.

    Kaplan S, Heiligenstein J, West S, Busner J, Harder D, Dittmann R, Casat C, Wernicke JF.

    J Atten Disord. 2004 Oct;8(2):45-52.PMID: 15801334 [PubMed - indexed for MEDLINE]Related citations

    4.

    Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder.

    Spencer T, Heiligenstein JH, Biederman J, Faries DE, Kratochvil CJ, Conners CK, Potter WZ.

    J Clin Psychiatry. 2002 Dec;63(12):1140-7.PMID: 12523874 [PubMed - indexed for MEDLINE]Related citations

    5.

    Efficacy of atomoxetine versus placebo in school-age girls with attention-deficit/hyperactivity disorder.

    Biederman J, Heiligenstein JH, Faries DE, Galil N, Dittmann R, Emslie GJ, Kratochvil CJ, Laws HF, Schuh KJ; Atomoxetine ADHD Study Group.

    Pediatrics. 2002 Dec;110(6):e75.PMID: 12456942 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    6.

    Spotlight on atomoxetine in adults with attention-deficit hyperactivity disorder.

    Simpson D, Plosker GL.

    CNS Drugs. 2004;18(6):397-401. Review.PMID: 15089111 [PubMed - indexed for MEDLINE]Related citations

    7.

    Atomoxetine: a review of its use in adults with attention deficit hyperactivity disorder.

    Simpson D, Plosker GL.

    Drugs. 2004;64(2):205-22. Review.PMID: 14717619 [PubMed - indexed for MEDLINE]Related citations

    8.

    Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies.

    Michelson D, Adler L, Spencer T, Reimherr FW, West SA, Allen AJ, Kelsey D, Wernicke J, Dietrich A, Milton D.

    Biol Psychiatry. 2003 Jan 15;53(2):112-20.PMID: 12547466 [PubMed - indexed for MEDLINE]Related citations

    9.

    Once-daily atomoxetine for adult attention-deficit/hyperactivity disorder: a 6-month, double-blind trial.

    Adler LA, Spencer T, Brown TE, Holdnack J, Saylor K, Schuh K, Trzepacz PT, Williams DW, Kelsey D.

    J Clin Psychopharmacol. 2009 Feb;29(1):44-50.PMID: 19142107 [PubMed - indexed for MEDLINE]Related citations

    10.

    Atomoxetine and adult attention-deficit/hyperactivity disorder: the effects of comorbidity.

    Spencer TJ, Faraone SV, Michelson D, Adler LA, Reimherr FW, Glatt SJ, Biederman J.

    J Clin Psychiatry. 2006 Mar;67(3):415-20.PMID: 16649828 [PubMed - indexed for MEDLINE]Related citations

    11.

    [Atomoxetine (Strattera), an alternative in the treatment of attention-deficit/hyperactivity disorder (ADHD) in children]

    Gaillez C, Sorbara F, Perrin E.

    Encephale. 2007 Sep;33(4 Pt 1):621-8. French. PMID: 18033153 [PubMed - indexed for MEDLINE]Related citations

    12.

    Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.

    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.

    Clin Ther. 2006 Feb;28(2):266-79.PMID: 16678648 [PubMed - indexed for MEDLINE]Related citations

    13.

    Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents-meta-analysis and meta-regression analysis.

    Cheng JY, Chen RY, Ko JS, Ng EM.

    Psychopharmacology (Berl). 2007 Oct;194(2):197-209. Epub 2007 Jun 16.PMID: 17572882 [PubMed - indexed for MEDLINE]Related citations

    14.

    Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study.

    Michelson D, Faries D, Wernicke J, Kelsey D, Kendrick K, Sallee FR, Spencer T; Atomoxetine ADHD Study Group.

    Pediatrics. 2001 Nov;108(5):E83.PMID: 11694667 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    15.

    Evaluation of atomoxetine for first-line treatment of newly diagnosed, treatment-naïve children and adolescents with attention deficit/hyperactivity disorder.

    Montoya A, Hervas A, Cardo E, Artigas J, Mardomingo MJ, Alda JA, Gastaminza X, García-Polavieja MJ, Gilaberte I, Escobar R.

    Curr Med Res Opin. 2009 Nov;25(11):2745-54.PMID: 19785510 [PubMed - indexed for MEDLINE]Related citations

    16.

    Efficacy and safety of atomoxetine as add-on to psychoeducation in the treatment of attention deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled study in stimulant-naïve Swedish children and adolescents.

    Svanborg P, Thernlund G, Gustafsson PA, Hägglöf B, Poole L, Kadesjö B.

    Eur Child Adolesc Psychiatry. 2009 Apr;18(4):240-9. Epub 2009 Jan 20.PMID: 19156355 [PubMed - indexed for MEDLINE]Related citations

    17.

    Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders.

    Wilens TE, Adler LA, Weiss MD, Michelson D, Ramsey JL, Moore RJ, Renard D, Brady KT, Trzepacz PT, Schuh LM, Ahrbecker LM, Levine LR; Atomoxetine ADHD/SUD Study Group.

    Drug Alcohol Depend. 2008 Jul 1;96(1-2):145-54. Epub 2008 Apr 9.PMID: 18403134 [PubMed - indexed for MEDLINE]Related citations

    18.

    A randomized, double-blind, placebo-controlled clinical trial on once-daily atomoxetine in Taiwanese children and adolescents with attention-deficit/hyperactivity disorder.

    Gau SS, Huang YS, Soong WT, Chou MC, Chou WJ, Shang CY, Tseng WL, Allen AJ, Lee P.

    J Child Adolesc Psychopharmacol. 2007 Aug;17(4):447-60.PMID: 17822340 [PubMed - indexed for MEDLINE]Related citations

    19.

    Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.

    Dell'Agnello G, Maschietto D, Bravaccio C, Calamoneri F, Masi G, Curatolo P, Besana D, Mancini F, Rossi A, Poole L, Escobar R, Zuddas A; LYCY Study Group.

    Eur Neuropsychopharmacol. 2009 Nov;19(11):822-34. Epub 2009 Aug 28.PMID: 19716683 [PubMed - indexed for MEDLINE]Related citations

    20.

    Atomoxetine and stroop task performance in adult attention-deficit/hyperactivity disorder.

    Faraone SV, Biederman J, Spencer T, Michelson D, Adler L, Reimherr F, Seidman L.

    J Child Adolesc Psychopharmacol. 2005 Aug;15(4):664-70.PMID: 16190797 [PubMed - indexed for MEDLINE]Related citations

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...
    You are here: NCBI > Literature > PubMed
    Write to the Help Desk